Welcome to the official website of the Ethypharm Group. This website is regulated by the Code of Best Practices of the International Federation of Pharmaceutical Manufacturers. Some information on this site may not be in conformity with French regulations on advertising. By continuing your navigation, you accept this website's use of cookies.

News & Press releases

Check here for our latest news, press releases, and publications.

NEWS

Integration of Partnered and International Sales Groups – Eric Vick is appointed Vice President of Global Channel Sales

The successful integration of Ethypharm and Martindale since the merger in February 2017 has allowed us to form a company with greater global reach than ever before.  We have begun the process of cross selling Ethypharm and Martindale products and examples such as the launch of Noyada in France or Esomeprazole growth in the UK have shown us to be better together.  The International businesses have also been able to find new opportunities to take products such as Fencino and Zomorph into markets in MENA.

Ethypharm Group has assessed options for managing the business derived via our non-direct sales channels, and has decided to establish a new group, Global Channel Sales.

Global Channel Sales will encompass our growing list of distributors, license partners, and NGOs, generating sales across 80+ countries.  Our goal is to develop an organisation that can leverage our local expertise, proactively manage our established business relationships, and identify new growth opportunities.  With a target budget in excess of €140mn in 2018, the performance of the new group will be a core component of the overall Ethypharm Group success.

We are pleased to confirm that Eric Vick has been appointed as Vice President of Global Channel Sales. Eric brings to this role a strong pedigree in global sales management, a customer-focused business approach, and a drive to achieve the full potential of the business.

We wish Eric every success in this challenging new role.

Beverley Thompson has joined Ethypharm as HR Director UK

We are pleased to welcome Beverley Thompson as HR Director for Ethypharm UK.

As a member of the UK Leadership team, she will be responsible for business and management support for Human Resources and Communication.

Beverley has a BSc. (Hons) in Biological Sciences from Leicester University and post graduate teaching qualifications from Manchester University. She worked successfully as a teacher for a number of years and then made a change in career to join the pharmaceutical industry.

She joined Abbott Laboratories as a Medical Sales Representative and progressed her career within Abbott in Training Manager, Regional Sales Manager and HR Manager UK roles prior to taking a HR & Development Director role for Serono, initially covering the UK and then also Northern European. In 2000 she set up her own HR Consultancy and has since worked in pharmaceutical and other business sectors providing HR support to both large and small businesses. In 2016 she made a decision to move back into a company role and joined the UK FTSE 250 organisation, Berendsen plc, as a HR Director supporting their Workwear business across the UK, Scandinavia and Europe.

We welcome Beverley to Ethypharm and we wish her great success in her role.

PRESS RELEASES

Michael Harris becomes Ethypharm’s Chief Operating Officer

Ethypharm, a European specialty pharmaceutical company, announces the appointment of Michael Harris as Chief Operating Officer of the Ethypharm Group.

Learn more

Ethypharm and Camurus sign agreement for distribution of episil® in France

Camurus AB and Ethypharm announced today that they have entered into an agreement under which Ethypharm has obtained exclusive distribution rights for episil® oral liquid in France. Based on a patented technology, episil® is an innovative treatment for the management and relief of oral mucositis pain, a common treatment-limiting side effect of cancer therapies.

Learn more

By clicking on this link, you agree to leave our website.
Are you sure?
NO     YES